Novo Nordisk reprimanded for allegedly failing to disclose payments - The manufacturer of the weight loss jab Wegovy said it ...
A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback